NIH-funded research R01 grant

How microtubules help separate chromosomes during cell division

Official title: The role of microtubule dynamics in midzone driven chromosome segregation in anaphase

Funded at University of Virginia · NIH-11473196 · Data updated 2026-11-12

This project looks at how the tiny internal scaffolding of cells (microtubules) moves and controls chromosomes during division to help improve cancer treatments.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Virginia
NIH-funded
Lab location1 site (Charlottesville, United States)
Project startFebruary 3, 2022
Project endJanuary 31, 2027
Funding year2026
Award (this year)$25,227
NIH project number3R01GM144668-05S1
Project IDNIH-11473196 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates would be people with cancer who are willing to provide tumor samples or participate in future clinical studies related to drugs affecting cell division.

Less likely to help

Patients without cancer or whose disease is driven by non-dividing-cell mechanisms are unlikely to see direct benefit from this basic-science work.

What this research studies

Researchers use high-resolution 3-D imaging and cell models to watch microtubules in the central spindle as cells complete division. They will compare normal cells with genetically altered cells to see how microtubule growth and arrangement push or slow chromosomes. The team combines structural tomography with molecular tools to link microtubule behavior to chromosome movement. Findings may point to new ways to target cell division in cancer.

Why it matters

Potential benefit: If successful, this work could help guide the design of cancer drugs that target cell division more precisely and reduce harmful side effects.

How similar studies have gone: Existing cancer drugs already target microtubules, but using detailed 3-D midzone imaging to inform new therapies is a newer, more mechanistic approach.

Where this research is happening

  • University of Virginia
    Charlottesville, United States
    Active

Researchers

  • Principal investigator: Redemann, Stefanie — University of Virginia
  • Study coordinator: Redemann, Stefanie

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.